HealthBridge AI, a pioneering company dedicated to revolutionizing the healthcare landscape through artificial intelligence, proudly announces its latest funding round, raising an impressive $10 million in Series A funding. This substantial investment comes from a host of industry-leading venture capitalists who believe in HealthBridge AI's mission to enhance the healthcare experience and significantly improve patient outcomes. By harnessing the power of advanced AI algorithms, HealthBridge AI is poised to tackle some of the most pressing challenges within the healthcare system, including streamlining patient-provider communication, optimizing treatment plans, and increasing the efficiency of healthcare delivery. With this funding, the company plans to expand its innovative platform, integrating sophisticated machine learning tools that will enable healthcare professionals to make data-driven decisions in real-time. Additionally, HealthBridge AI aims to enhance its research capabilities, ultimately leading to groundbreaking advancements in predictive analytics and personalized medicine. The funding will also support the growth of the dedicated team behind HealthBridge AI, allowing the company to attract top talent in both technology and healthcare fields. As HealthBridge AI continues to pave the way toward a more efficient and patient-centric healthcare system, this latest investment marks a significant milestone in its journey to create intelligent solutions that empower patients and providers alike. The future of healthcare is here, and HealthBridge AI is at the forefront, ready to make a meaningful impact on quality of care.
HealthBridge AI Secures Pre-Seed Funding to Revolutionize Healthcare with AI-Powered Solutions
Recently funded · Pre-seedHealthcare
Get the full HealthBridge AI company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Pre-seed rounds
Companies that recently closed a Pre-seed round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Dognosis India | Pre-seed | $1.5M | today |
| 2 | Dognosis India | Pre-seed | $1.5M | today |
